Retrospective Assessment of Treatment Patterns and Outcomes Associated with Palbociclib in Combination With Letrozole in Postmenopausal Women With HR+/HER2– Advanced Breast Cancer

Study type

• Study topic:
  Disease /health condition

  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation
• Data collection methods:
  Secondary use of data

Non-interventional study

• Non-interventional study design:
  Other
• Non-interventional study design, other:
  Retrospective medical record review

Study drug and medical condition

• Medicinal product name:
  IBRANCE
• Medical condition to be studied:
  Breast cancer metastatic

Population studied

• Short description of the study population:
  Postmenopausal Women With HR+/HER2– Advanced Breast Cancer who received palbociclib plus letrozole.
• Age groups:
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)
• Special population of interest:
  Other
• Special population of interest, other:
  Advanced Breast Cancer patients
• Estimated number of subjects:
  130

Study design details

• Main study objective:
  The main objective of this study is to evaluate treatment patterns and outcomes among patients who received palbociclib plus letrozole
• Data analysis plan:
  Descriptive analyses only, no hypotheses being tested